| Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RC Group Lancet Respiratory Medicine 9 (12), 1419-1426, 2021 | 1974* | 2021 |
| Initiation of sacubitril/valsartan in haemodynamically stabilised heart failure patients in hospital or early after discharge: primary results of the randomised TRANSITION study R Wachter, M Senni, J Belohlavek, E Straburzynska‐Migaj, KK Witte, ... European journal of heart failure 21 (8), 998-1007, 2019 | 359 | 2019 |
| Left ventricular midwall fibrosis as a predictor of mortality and morbidity after cardiac resynchronization therapy in patients with nonischemic cardiomyopathy F Leyva, RJ Taylor, PWX Foley, F Umar, LJ Mulligan, K Patel, ... Journal of the American College of Cardiology 60 (17), 1659-1667, 2012 | 294 | 2012 |
| Semaglutide in patients with heart failure with preserved ejection fraction and obesity MN Kosiborod, SZ Abildstrøm, BA Borlaug, J Butler, S Rasmussen, ... New England Journal of Medicine 389 (12), 1069-1084, 2023 | 248 | 2023 |
| Cardiac resynchronization therapy guided by late gadolinium-enhancement cardiovascular magnetic resonance F Leyva, PWX Foley, S Chalil, K Ratib, REA Smith, F Prinzen, A Auricchio Journal of Cardiovascular Magnetic Resonance 13 (1), 29, 2011 | 233 | 2011 |
| Late gadolinium enhancement-cardiovascular magnetic resonance as a predictor of response to cardiac resynchronization therapy in patients with ischaemic cardiomyopathy S Chalil, PWX Foley, SA Muyhaldeen, KCR Patel, ZR Yousef, REA Smith, ... Europace 9 (11), 1031-1037, 2007 | 222 | 2007 |
| Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 400 (10349), 359-368, 2022 | 220 | 2022 |
| Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded … PR Kalra, JGF Cleland, MC Petrie, EA Thomson, PA Kalra, IB Squire, ... The Lancet 400 (10369), 2199-2209, 2022 | 182 | 2022 |
| Effect of posterolateral left ventricular scar on mortality and morbidity following cardiac resynchronization therapy S Chalil, B Stegemann, SA Muhyaldeen, K Khadjooi, PW Foley, ... Pacing and Clinical Electrophysiology 30 (10), 1201-1209, 2007 | 168 | 2007 |
| Long-term effects of cardiac resynchronisation therapy in patients with atrial fibrillation K Khadjooi, PW Foley, S Chalil, J Anthony, REA Smith, MP Frenneaux, ... Heart 94 (7), 879-883, 2008 | 154 | 2008 |
| His bundle pacing, learning curve, procedure characteristics, safety, and feasibility: insights from a large international observational study D Keene, AD Arnold, M Jastrzębski, H Burri, S Zweibel, E Crespo, ... Journal of cardiovascular electrophysiology 30 (10), 1984-1993, 2019 | 148 | 2019 |
| Randomized, controlled trial of intramuscular or intracoronary injection of autologous bone marrow cells into scarred myocardium during CABG versus CABG alone KL Ang, D Chin, F Leyva, P Foley, C Kubal, S Chalil, L Srinivasan, ... Nature clinical practice Cardiovascular medicine 5 (10), 663-670, 2008 | 135 | 2008 |
| Cardiac resynchronization therapy delivered via a multipolar left ventricular lead is associated with reduced mortality and elimination of phrenic nerve stimulation: long‐term … JM Behar, J Bostock, APO ZHU LI, HMS Chin, S Jubb, E Lent, J Gamble, ... Journal of cardiovascular electrophysiology 26 (5), 540-546, 2015 | 122 | 2015 |
| What is treatment success in cardiac resynchronization therapy? PWX Foley, F Leyva, MP Frenneaux Europace 11 (suppl_5), v58-v65, 2009 | 114 | 2009 |
| Outcomes of cardiac resynchronization therapy with or without defibrillation in patients with nonischemic cardiomyopathy F Leyva, A Zegard, E Acquaye, C Gubran, R Taylor, PWX Foley, F Umar, ... Journal of the American College of Cardiology 70 (10), 1216-1227, 2017 | 86 | 2017 |
| Growth differentiation factor-15 predicts mortality and morbidity after cardiac resynchronization therapy PWX Foley, B Stegemann, K Ng, S Ramachandran, A Proudler, ... European heart journal 30 (22), 2749-2757, 2009 | 85 | 2009 |
| Long-term effects of upgrading from right ventricular pacing to cardiac resynchronization therapy in patients with heart failure PWX Foley, SA Muhyaldeen, S Chalil, REA Smith, JE Sanderson, F Leyva Europace 11 (4), 495-501, 2009 | 85 | 2009 |
| Left ventricular reverse remodelling, long‐term clinical outcome, and mode of death after cardiac resynchronization therapy PWX Foley, S Chalil, K Khadjooi, N Irwin, REA Smith, F Leyva European journal of heart failure 13 (1), 43-51, 2011 | 75 | 2011 |
| Incidental cardiac findings on computed tomography imaging of the thorax PWX Foley, A Hamaad, H El-Gendi, F Leyva BMC research notes 3, 1-4, 2010 | 70 | 2010 |
| His bundle pacing: a new strategy for physiological ventricular activation AJM Lewis, P Foley, Z Whinnett, D Keene, B Chandrasekaran Journal of the American Heart Association 8 (6), e010972, 2019 | 67 | 2019 |
Francisco LeyvaProfessor of CardiologyVerified email at uhb.nhs.uk
